Hospitals | May 20, 2022
Sparsh Hospital introduces ‘Infinite care’ joint replacement programme
‘Infinite Care’ comprises two key pillars - Sparsh Sankalpa and Sparsh Sukshema
‘Infinite Care’ comprises two key pillars - Sparsh Sankalpa and Sparsh Sukshema
First disclosure from PILOT study of Breyanzi in second-line large B-cell lymphoma underscores important role of cell therapy earlier in treatment paradigm
Dxcover announced that it will be presenting new data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, June 3-7
Leading pharma companies are achieving rapid, large-scale performance improvements using a multifaceted approach that realizes short-term gains & builds long-term capabilities at the same time
A post approval change order is often necessary, but innovators should plan and prepare for this pre-approval. Planning alongside outsourcing partners will help ensure that only a small-scale study is needed—not a new full clinical study
City of Hope is first in world to test oncolytic virus, CF33-hNIS, in people with metastatic solid tumours
Viralex (Inosine Pranobex) is an immunomodulatory agent with broad-spectrum antiviral properties
Wearable patch sensors (smart patches) are rising in popularity, as they offer a wide range of options for medical diagnosis
Union Minister of State for Science and Technology, Dr Jitendra Singh gave the award for the successful commercialization of indigenous technology on National Technology Day 2022
Potential new treatment for progressive pulmonary fibrosis (PPF) builds on Boehringer Ingelheim’s leadership in lung fibrosis and will be further investigated in a phase III clinical trial program
Subscribe To Our Newsletter & Stay Updated
